ICRF has awarded more than $98 million in funding to support over 2,800 grants to outstanding cancer researchers at all leading institutions in Israel as well as collaborative research partnerships between Israeli and North American investigators. Many of our grantees are responsible for major cancer research breakthroughs and discoveries.

Recipient(s) Institution Grant Type Research Topics Grant Status
Itai Benhar, PhD Tel Aviv University Project Grant Immunology and Immunotherapy, Leukemia, Lymphoma Active
Michael Berger, PhD Hebrew University of Jerusalem Project Grant Animal Modes of Cancer, Bone Cancers, Brain Cancer, Cancer Metastasis, Colorectal Cancer, Human Subjects, Immunology and Immunotherapy, Men’s Cancers, Metabolism and Cancer, Pancreatic Cancer, Pediatric Cancer, Renal Cancer, Skin Cancer, Women’s Cancers Non-active
Michael Berger, PhD Hebrew University of Jerusalem Project Grant Cancer Treatment, Immunology and Immunotherapy Active
Yehudit Bergman, PhD Hebrew University-Hadassah Medical School Research Professorship Grant Breast Cancer, Cancer Stem Cells, Colorectal Cancer, Inflammation and Cancer Non-active
Benjamin Berman, PhD Hebrew University of Jerusalem Project Grant Cancer Genetics and Epigenetics Active
Galia Blum, PhD Hebrew University of Jerusalem Project Grant Immunology and Immunotherapy, Lung Cancer Active
Limor Broday, PhD Tel Aviv University Acceleration Grant Cell Signaling, Genetics and Genomics, Lung Cancer, Model Organisms, Oncogenesis Non-active
Michal Brunwasser-Meirom, PhD Technion, Israel Institute of Technology Postdoctoral Fellowship Experimental Therapeutics Non-active
Yosef Buganim, PhD Hebrew University of Jerusalem Project Grant Breast Cancer, Cancer Stem Cells Active
Tal Burstyn-Cohen, PhD Hebrew University of Jerusalem Project Grant Brain Cancer, Cancer Treatment, Inhibiting Tumor Growth Active